The global peripheral vascular devices market size is projected to reach USD 13.4 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 5.3% from 2021 to 2026.

To know about the assumptions considered for the study download the pdf brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790

The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favorable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption.

Global Peripheral Vascular Devices Market Scope:

Metrics

Details

Study Period

2019–2026

Market Size in 2025

USD 13.4 Billion

Segment Covered

Type, Specialty, Application, End User and Region

by Type Covered

Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices

Regions Covered

North America, Europe, Asia Pacific, Middle East and Africa, and South America

Key Players Profiled

Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (US), Merit Medical Systems (US), Penumbra, Inc.(US), Koninklijke Philips N.V.( Netherlands), iVascular S.L.U (Spain), Biosensors International Group Ltd. (Singapore), BIOTRONIK (Germany), AMG International GmbH (US)



Medtronic (Ireland) held the leading position in the peripheral vascular devices market in 2020. The company offers an exhaustive product portfolio consisting of various peripheral vascular devices. The company’s strong heritage of technology, leadership, and innovation has provided a solid foundation for the continued development of safe and cost-effective products.

Boston Scientific Corporation (US) Boston Scientific Corporation accounted for the second-largest share of the global peripheral vascular devices in 2020. The company provides its robust portfolio of peripheral vascular devices and efforts to develop innovative products by investing in R&D.

Click Here to Access a Free Sample Report of the Global Peripheral Vascular Devices Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=790

Recent Developments:

Medtronic received the US FDA approval for its IN. PACT AV drug-coated balloon (DCB) to treat arteriovenous fistula lesions
Boston Scientific Corporation received the FDA Approval for its VICI VENOUS STENT System for treating patients with deep venous blockages.
Our Free Sample Report Consists of the following:

Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
About 220+ Pages Research Report (Including Recent Research)
Provide detailed chapter-by-chapter guidance on Request
Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
Includes Tables and figures have been updated
The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Directly Purchase a copy of the report [347] @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?i...